Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratesWith |
gptkb:Merck_&_Co.
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
drug discovery
immuno-oncology metabolic diseases ophthalmic diseases |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:Jung_Choi
Jens H. Vogel William J. Rieflin |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NGM Biopharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
David J. Woodhouse
H. Martin Seidel Jens H. Vogel |
| gptkbp:notableProduct |
NGM120
NGM313 NGM621 NGM707 |
| gptkbp:numberOfEmployees |
100-200 (approximate)
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:NGM
|
| gptkbp:website |
https://www.ngmbio.com/
|
| gptkbp:bfsParent |
gptkb:The_Column_Group
|
| gptkbp:bfsLayer |
7
|